• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Hayashi Masami  林 正美

ORCIDConnect your ORCID iD *help
… Alternative Names

HAYASHI Masami  林 正美

Less
Researcher Number 00551748
Other IDs
Affiliation (Current) 2022: 大阪医科薬科大学, 医学部, 准教授
Affiliation (based on the past Project Information) *help 2021 – 2022: 大阪医科薬科大学, 医学部, 准教授
2018 – 2020: 大阪医科大学, 医学部, 准教授
2014 – 2017: 大阪医科大学, 医学部, 講師
2012 – 2015: 大阪医科大学, 医学部, 助教
2011: Osaka University, 医学(系)研究科(研究院), 助教
2009 – 2010: Osaka University, 医学系研究科, 助教
Review Section/Research Field
Principal Investigator
Obstetrics and gynecology / Basic Section 56040:Obstetrics and gynecology-related
Except Principal Investigator
Obstetrics and gynecology / Basic Section 56040:Obstetrics and gynecology-related
Keywords
Principal Investigator
子宮頚癌 / マイクロRNA / miRNA / 卵巣癌 / 抗癌剤耐性 / Akt / mTOR / c-myc / MYCBP / c-Myc … More / exosome / エクソソーム / 癌 / 子宮頸癌 / 癌免疫治療 … More
Except Principal Investigator
卵巣癌 / EMT / CD24 / 高分子ミセル / BNCT / 子宮頸癌 / 子宮内膜癌 / Met / 上皮間葉形態転換 / 婦人科悪性腫瘍 / 抗がん剤 / 抗癌剤 / MET / 癌関連繊維芽細胞 / 子宮体がん / 肥満 / 脂肪細胞 / 細胞外小胞 / オルガノイド / HGF / ABC transporter / ミセル / Foretinib / ミセル / 血管内皮障害 / フィブラート / 一酸化窒素 / TC療法 / 動脈硬化 / 血管内皮機能 / 明細胞腺癌 / AMH / AMH: 146 T>G / -482 A>G / IVS1+149 T>A / IVS5-6 C>T / AMHR / 抗ミュウラー管ホルモン / 子宮内膜症 / 不妊 / 体外受精 / 一塩基多型 / SNP / AMH 146T>G / AMHRII+149 T>A / ISV10+77 A>G / ISV5−6 C>T / Genotyping assay / ドラッグデリバリー / 腹膜播種転移 / 薬剤耐性 / 卵巣がん / drug delivery system / E-cadherin / Snail / colony formation / シスプラチン耐性 / シスプラチン / 耐性 / 早期発見 / 卵巣毒性 / アルキル化剤 / 顆粒膜細胞 / テストステロン / AMH / 卵巣保護 / GPR30 / EMT現象 / 不育症 / ES細胞 / 血管内皮前駆細胞 / 妊娠高血圧腎症モデルマウス / 流産モデルマウス / iPS細胞 / 子宮胎盤形成不全症 / 胎盤形成不全 / 骨髄由来内皮前駆細胞 / 不育症マウス / 流産マウス / 流産 / 妊娠高血圧症候群 / 妊娠高血圧腎症 / EPC / 子宮内胎児発育不全 / 妊娠高血圧腎症腎症 / 胎盤 / miRNA / 浸潤・転移 / mi RNA / エキソソーム / 癌関連線維芽細胞 / 子宮体癌 / lipid raft / 化学療法抵抗性 / CD24 / EMT / GPIアンカー型タンパク質 / ラフト形成 / 婦人科癌 / GPIアンカー型蛋白質 / 腫瘍随伴マクロファージ / FABP4 / がん関連繊維芽細胞 / がん / アディポカイン / がん微小環境 / 癌幹細胞 / ドラッグデリバリーシステム / 上皮・間葉形態転換 / ニッチ / Endothelinー2 / 子宮頸がん / 硼素化合物 / 硼素内包高分子ミセル / 難治性卵巣癌 / エリブリン / 腫瘍免疫 / 免疫応答 / T細胞 / PDX / 臨床腫瘍直接移植モデル / EVs / 腫瘍直接移植モデル / Te-EVs / PDX / エクソソーム / 再発 / 硼素中性子捕捉療法 / LAT-1 / 同時化学放射線療法 / 癌免疫 Less
  • Research Projects

    (27 results)
  • Research Products

    (21 results)
  • Co-Researchers

    (24 People)
  •  卵巣癌再発・転移に対して硼素中性子捕捉療法の有用性の検討

    • Principal Investigator
      恒遠 啓示
    • Project Period (FY)
      2022 – 2024
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56040:Obstetrics and gynecology-related
    • Research Institution
      Osaka Medical and Pharmaceutical University
  •  硼素中性子捕捉療法とLAT1を介した化学療法を併用する子宮頸癌の新たな治療戦略

    • Principal Investigator
      寺田 信一
    • Project Period (FY)
      2022 – 2024
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56040:Obstetrics and gynecology-related
    • Research Institution
      Osaka Medical and Pharmaceutical University
  •  癌特異的EVs内のmiRNAをターゲットとした腫瘍免疫システムの機序解明

    • Principal Investigator
      田中 智人
    • Project Period (FY)
      2022 – 2024
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56040:Obstetrics and gynecology-related
    • Research Institution
      Osaka Medical and Pharmaceutical University
  •  卵巣癌オルガノイドを用いた脂肪細胞によるがん浸潤・転移機構の解明

    • Principal Investigator
      佐々木 浩
    • Project Period (FY)
      2021 – 2023
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56040:Obstetrics and gynecology-related
    • Research Institution
      Osaka Medical and Pharmaceutical University
  •  3次元オルガノイド培養を用いた難治性卵巣癌の個別化医療の構築

    • Principal Investigator
      大道 正英
    • Project Period (FY)
      2020 – 2022
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56040:Obstetrics and gynecology-related
    • Research Institution
      Osaka Medical and Pharmaceutical University
  •  複合的癌免疫治療による子宮頚癌治療の革新的開発Principal Investigator

    • Principal Investigator
      林 正美
    • Project Period (FY)
      2019 – 2022
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56040:Obstetrics and gynecology-related
    • Research Institution
      Osaka Medical and Pharmaceutical University
  •  Analysis of extracellular vesicles using patient derived xenograft

    • Principal Investigator
      田中 智人
    • Project Period (FY)
      2019 – 2022
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56040:Obstetrics and gynecology-related
    • Research Institution
      Osaka Medical and Pharmaceutical University
  •  Target therapy of ovarian cancer including immunotherapy via Eribulin

    • Principal Investigator
      FUJIWARA SATOE
    • Project Period (FY)
      2018 – 2020
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56040:Obstetrics and gynecology-related
    • Research Institution
      Osaka Medical College
  •  Research for cancer microenvironment via FABP4 in endometrial cnacer

    • Principal Investigator
      Sasaki Hiroshi
    • Project Period (FY)
      2017 – 2019
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Osaka Medical College
  •  Development of a new therapy for refractory ovarian cancer via liposomal nanoparticle targeting control of EMT

    • Principal Investigator
      Ohmichi Masahide
    • Project Period (FY)
      2017 – 2019
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Osaka Medical College
  •  Treatment strategy of boron neutron capture therapy in cervical cancer

    • Principal Investigator
      Tsunetoh Satoshi
    • Project Period (FY)
      2017 – 2019
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Osaka Medical College
  •  The New therapy of placental insufficiency ~ Endothelial progenitor cells for angiojenesis and new anticoagulant therapy

    • Principal Investigator
      Kanki Kazuyoshi
    • Project Period (FY)
      2016 – 2018
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Osaka Medical College
  •  A novel miRNA regulates the EMT and MMT of peritoneal mesothelium in ovarian cancer

    • Principal Investigator
      Terai Yoshito
    • Project Period (FY)
      2016 – 2018
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Kobe University
      Osaka Medical College
  •  activation regulatory mechanism of cancer fibroblast by obesity

    • Principal Investigator
      Takai Masaaki
    • Project Period (FY)
      2016 – 2018
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Osaka Medical College
  •  A novel approach for cervical cancer using exosomePrincipal Investigator

    • Principal Investigator
      Hayashi Masami
    • Project Period (FY)
      2016 – 2018
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Osaka Medical College
  •  Analysis of lipid raft via CD24 and drug resistance in gynecologic cancer

    • Principal Investigator
      Tanaka Yoshimichi
    • Project Period (FY)
      2016 – 2018
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Osaka Medical College
  •  Testosterone for the Prevention of Cyclophosphamide -Induced Ovarian Toxicity

    • Principal Investigator
      Tanabe Akiko
    • Project Period (FY)
      2015 – 2017
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Osaka Medical College
  •  GPR30 signaling regulates Epithelial-Mesenchymal Transition in ovarian cancer

    • Principal Investigator
      Fujiwara Satoe
    • Project Period (FY)
      2015 – 2017
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Osaka Medical College
  •  Analyzing the possible involvement of anti-Müllerian hormon and anti-Müllerian hormon receptor II single nucleotide polymorphism in infertility

    • Principal Investigator
      Yamashita Yoshiki
    • Project Period (FY)
      2013 – 2015
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Osaka Medical College
  •  Potential therapeutic target of microRNA in cervical cancer.Principal Investigator

    • Principal Investigator
      Masami Hayashi
    • Project Period (FY)
      2013 – 2015
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Osaka Medical College
  •  CD24-targeting drug delivery system enhanced effect of cisplatin-resistant ovarian cancer cells

    • Principal Investigator
      TERAI YOSHITO
    • Project Period (FY)
      2013 – 2015
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Osaka Medical College
  •  Development of anticancer drug resistance evaluation system, and early recurrence-detection tools in ovarian cancer

    • Principal Investigator
      Ohmichi Masahide
    • Project Period (FY)
      2013 – 2015
    • Research Category
      Grant-in-Aid for Challenging Exploratory Research
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Osaka Medical College
  •  To control in invasion and metastasis through EMT (Epithelial-Mesenchymal-Transition) functional analysis of CD24 in endometrial cancer

    • Principal Investigator
      OHMICHI Masahide
    • Project Period (FY)
      2012 – 2014
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Osaka Medical College
  •  Fibrates protect against vascular endothelial dysfunction induced by paclitaxel and carboplatin chemotherapy for cancer patients: a pilot study.

    • Principal Investigator
      TANABE Akiko
    • Project Period (FY)
      2012 – 2014
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Osaka Medical College
  •  Control of EMT phenomenon by mTOR inhiibitor for ovarian clear cell carcinoma.

    • Principal Investigator
      TSUNETOH Satoshi
    • Project Period (FY)
      2012 – 2014
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Osaka Medical College
  •  子宮頸癌に対するC-myc結合蛋白を標的とした分子標的治療の可能性の検討Principal Investigator

    • Principal Investigator
      林 正美
    • Project Period (FY)
      2011
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Osaka University
  •  Analysis of anticancer drug-resistant ovarian cancer cells under hypoxic tumor microenvironmentPrincipal Investigator

    • Principal Investigator
      HAYASHI Masami
    • Project Period (FY)
      2009 – 2010
    • Research Category
      Grant-in-Aid for Research Activity Start-up
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Osaka University

All 2021 2020 2019 2018 2017 2015 2014 2011 2010 2009

All Journal Article Presentation

  • [Journal Article] Serum Exosomal microRNA-34a as a Potential Biomarker in Epithelial Ovarian Cancer2021

    • Author(s)
      Maeda K, Sasaki H, Ueda S, Miyamoto S, Terada S, Konishi H, Kogata Y, Ashihara K, Fujiwara S, Tanaka Y, Tanaka T, Hayashi M, Ito Y, Kondo Y, Ochiya T, Ohmichi M
    • Journal Title

      J Ovarian Res

      Volume: 13 Pages: 47-47

    • DOI

      10.1186/s13048-020-00648-1

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K09838, KAKENHI-PROJECT-16K10482, KAKENHI-PROJECT-17K11303
  • [Journal Article] The Protective Effect of Testosterone on the Ovarian Reserve During Cyclophosphamide Treatment2020

    • Author(s)
      Yoo M, Tanaka T, Konishi H, Tanabe A, Taniguchi K, Komura K, Hayashi M, Ohmichi M.
    • Journal Title

      Onco Targets Ther

      Volume: 13 Pages: 2987-2995

    • DOI

      10.2147/ott.s242703

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K09838
  • [Journal Article] Pharmacokinetic Evaluation and Antitumor Potency of Liposomal Nanoparticle Encapsulated Cisplatin Targeted to CD24-positive Cells in Ovarian Cancer2020

    • Author(s)
      Ashihara K, Terai Y, Tanaka T, Tanaka Y, Fujiwara S, Maeda K, Tunetoh S, Sasaki H, Hayashi M, Ohmichi M.
    • Journal Title

      Oncol Lett

      Volume: 19 Pages: 1872-1880

    • DOI

      10.3892/ol.2020.11279

    • NAID

      120006873100

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K09838, KAKENHI-PROJECT-17K11303, KAKENHI-PROJECT-17K11304
  • [Journal Article] Foretinib (GSK1363089) induces p53-dependent apoptosis in endometrial cancer2018

    • Author(s)
      Kogata Y, Tanaka T,Ono Y, Hayashi M, Terai Y, Ohmichi M.
    • Journal Title

      Oncotarget

      Volume: 9 Pages: 22769-22784

    • DOI

      10.18632/oncotarget.25232

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K11303, KAKENHI-PROJECT-16K11165
  • [Journal Article] Recombinant human soluble thrombomodulin as an anticoagulation therapy improves recurrent miscarriage and fetal growth restriction due to placental insufficiency ? The leading cause of preeclampsia2018

    • Author(s)
      Sano Takumi、Terai Yoshito、Daimon Atsushi、Nunode Misa、Nagayasu Yoko、Okamoto Atsuko、Fujita Daisuke、Hayashi Masami、Ohmichi Masahide
    • Journal Title

      Placenta

      Volume: 65 Pages: 1-6

    • DOI

      10.1016/j.placenta.2018.03.006

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-16K11165
  • [Journal Article] CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways2017

    • Author(s)
      Nakamura K, Terai Y, Tanabe A, Ono YJ, Hayashi M, Maeda K, Fujiwara S, Ashihara K, Nakamura M, Tanaka Y, Tanaka T, Tsunetoh S, Sasaki H, Ohmichi M.
    • Journal Title

      Oncology Reports

      Volume: - Pages: 3189-3200

    • DOI

      10.3892/or.2017.5583

    • Peer Reviewed / Acknowledgement Compliant / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26462541, KAKENHI-PROJECT-16K11162, KAKENHI-PROJECT-16K11165, KAKENHI-PROJECT-17K11304
  • [Journal Article] Met Signaling Cascade Is Amplified by the Recruitment of Phosphorylated Met to Lipid Rafts via CD24 and Leads to Drug Resistance in Endometrial Cancer Cell Lines.2015

    • Author(s)
      Ono YJ, Tanabe A, Tanaka T, Tanaka Y, Hayashi M, Terai Y, Ohmichi M.
    • Journal Title

      Molecular Cancer Therapeutics

      Volume: 14 Pages: 2353-2363

    • DOI

      10.1158/1535-7163.mct-15-0187

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-25670709
  • [Journal Article] Analysis of the methylation rate of the androgen receptor promoter region in granulosa cells in moderate to severe endometriosis patients undergoing controlled ovarian hyperstimulation2015

    • Author(s)
      Yoko Nakamura, M.D., Yoshiki Yamashita, M.D., Natsuho Saito, M.D., Hikaru Yamamoto M.D., Masami Hayashi, M.D. Yoshito Terai, M.D., Masahide Ohmichi, M.D.
    • Journal Title

      Journal of Reproductive Endocrinology & Infertility

      Volume: 1 Pages: 1-5

    • Peer Reviewed / Acknowledgement Compliant / Open Access
    • Data Source
      KAKENHI-PROJECT-25462581
  • [Journal Article] Hepatocyte growth factor secreted by ovarian cancer cells stimulates peritoneal implantation via the mesothelial-mesenchymal transition of the peritoneum.2015

    • Author(s)
      Michihiko Nakamura, Yoshihiro J Ono, Masanori Kanemura, Tomohito Tanaka, Masami Hayashi, Yhoshito Terai, Masahide Ohmichi
    • Journal Title

      Gynecologic Oncology

      Volume: 139 Pages: 345-354

    • DOI

      10.1016/j.ygyno.2015.08.010

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-25462620, KAKENHI-PROJECT-25670709
  • [Journal Article] Estradiol-mediated hepatocyte growth factor is involved in the implantation of endometriotic cells via the mesothelial-to-mesenchymal transition in the peritoneum.2015

    • Author(s)
      Ono YJ, Hayashi M, Tanabe A, Hayashi A, Kanemura M, Terai Y, Ohmichi M.
    • Journal Title

      American Journal of Physiology-Endocrinology and Metabolism

      Volume: Apr 7

    • DOI

      10.1152/ajpendo.00573.2014

    • Peer Reviewed / Acknowledgement Compliant / Open Access
    • Data Source
      KAKENHI-PROJECT-24390384, KAKENHI-PROJECT-25462619, KAKENHI-PROJECT-25462620, KAKENHI-PROJECT-25670709
  • [Journal Article] Analyzing the possible involvement of anti-Müllerian hormone and anti-Müllerian hormone receptor II single nucleotide polymorphism in infertility.2014

    • Author(s)
      Yoko Yoshida, Yoshiki Yamashita, Atushi Hayashi,
    • Journal Title

      Journal of assisted reproduction and genetics

      Volume: 2 Pages: 163-168

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-25462581
  • [Journal Article] Decorin induced by progesterone plays a crucial role in suppressing endometriosis.2014

    • Author(s)
      Ono YJ, Terai Y, Tanabe A, Hayashi A, Hayashi M, Yamashita Y, Kyo S, Ohmichi
    • Journal Title

      J Endocrinol

      Volume: 223 Pages: 203-216

    • DOI

      10.1530/joe-14-0393

    • Peer Reviewed / Acknowledgement Compliant
    • Data Source
      KAKENHI-PROJECT-24390384
  • [Journal Article] Requirement of evading apoptosis for HIF-1α-induced malignant progression in mouse cells.2011

    • Author(s)
      Hayashi M, Yoo YG, Christensen J, Huang LE.
    • Journal Title

      Cell Cycle. in press

    • Data Source
      KAKENHI-PROJECT-21890130
  • [Journal Article] Vascular endothelial growth factor is a promising therapeutic target for the treatment of clear cell carcinoma of the ovary.2010

    • Author(s)
      Mabuchi S, Kawase C, Altomare DA, Morishige K, Hayashi M, Sawada K, Ito K, Terai Y, Nishio Y, Klein-Szanto AJ, Burger RA, Ohmichi M, Testa JR, Kimura T.
    • Journal Title

      Mol Cancer Ther 9

      Pages: 2411-2422

    • Data Source
      KAKENHI-PROJECT-21890130
  • [Journal Article] An essential role of the HIF-1alpha-c-Myc axis in malignant progression.2009

    • Author(s)
      Yoo YG, Hayashi M, Christensen J, Huang LE.
    • Journal Title

      Ann N Y Acad Sci. 1177

      Pages: 198-204

    • Data Source
      KAKENHI-PROJECT-21890130
  • [Journal Article] mTOR is a promising therapeutic target both in cisplatin-sensitive and cisplatin-resistant clear cell carcinoma of the ovary.2009

    • Author(s)
      Mabuchi S, Kawase C, Altomare DA, Morishige K, Sawada K, Hayashi M, Tsujimoto M, Yamoto M, Klein-Szanto AJ, Schilder RJ, Ohmichi M, Testa JR, Kimura T.
    • Journal Title

      Clin Cancer Res. 15

      Pages: 5404-5413

    • Data Source
      KAKENHI-PROJECT-21890130
  • [Journal Article] mTOR is a promising therapeutic target both in cisplatin-sensitive and cisplatin-resistant clear cell carcinoma of the ovary.2009

    • Author(s)
      Mabuchi S, Kawase C, Altomare DA, Morishige K, Sawada K, Hayashi M, et al.
    • Journal Title

      Clin Cancer Res. 15

      Pages: 5404-5413

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21890130
  • [Presentation] 卵巣明細胞癌に対する切除組織培養分泌エクソソームを用いた特異的腫瘍マーカーの開発2020

    • Author(s)
      丸岡 寛、田中智人、小西莉奈、飯藤宰士、石川 渚、大瀧瑠璃、上田尚子、宮本瞬輔、寺田信一、小西博巳、林 正美、大道正英
    • Organizer
      第72回日本産科婦人科学会
    • Data Source
      KAKENHI-PROJECT-19K09838
  • [Presentation] New approaches using exosome for cervical cancer treatment.2019

    • Author(s)
      Hiromi Konishi, Masami Hayashi, Shinichi Terada, Kana Kokunai, Natsuho Nakamura, Sayaka Taga, Satoe Fujiwara, Hiroshi Sasaki, Yoshito Terai, Masahide Ohmichi
    • Organizer
      第71回日本産科婦人科学会学術講演会
    • Data Source
      KAKENHI-PROJECT-19K09791
  • [Presentation] MicroRNA-22を介した子宮頸癌の分子標的治療への応用2017

    • Author(s)
      中村真由美、林正美、橋田宗祐、丸岡寛、小西博巳、前田和也、田中良道、佐々木浩、寺井義人、大道正英
    • Organizer
      日本産婦人科学会学術講演会
    • Data Source
      KAKENHI-PROJECT-16K11164
  • [Presentation] 難治性卵巣癌モデルマウスに対するCD24を標的とした高分子ミセルを用いた新規治療2017

    • Author(s)
      芦原 敬允, 寺井 義人, 土橋 裕允, 藤原 聡枝, 田中 良道, 田中 智人, 恒遠 啓示, 佐々木 浩, 林 正美, 大道 正英
    • Organizer
      第69回日本産科婦人科学会学術集会
    • Data Source
      KAKENHI-PROJECT-17K11304
  • 1.  OHMICHI Masahide (10283764)
    # of Collaborated Projects: 25 results
    # of Collaborated Products: 15 results
  • 2.  TANAKA Yoshimichi (10625502)
    # of Collaborated Projects: 22 results
    # of Collaborated Products: 10 results
  • 3.  TSUNETOH Satoshi (70388255)
    # of Collaborated Projects: 20 results
    # of Collaborated Products: 2 results
  • 4.  TERAI Yoshito (90278531)
    # of Collaborated Projects: 20 results
    # of Collaborated Products: 12 results
  • 5.  TANABE Akiko (70454543)
    # of Collaborated Projects: 15 results
    # of Collaborated Products: 4 results
  • 6.  Sasaki Hiroshi (80432491)
    # of Collaborated Projects: 15 results
    # of Collaborated Products: 6 results
  • 7.  Fujiwara Satoe (90707960)
    # of Collaborated Projects: 15 results
    # of Collaborated Products: 5 results
  • 8.  田中 智人 (90411363)
    # of Collaborated Projects: 9 results
    # of Collaborated Products: 2 results
  • 9.  KANEMURA Masanori (40298782)
    # of Collaborated Projects: 8 results
    # of Collaborated Products: 2 results
  • 10.  Yoo Saha (80625674)
    # of Collaborated Projects: 8 results
    # of Collaborated Products: 0 results
  • 11.  YAMASHITA Yoshiki (50268207)
    # of Collaborated Projects: 4 results
    # of Collaborated Products: 3 results
  • 12.  古形 祐平 (80829953)
    # of Collaborated Projects: 3 results
    # of Collaborated Products: 0 results
  • 13.  Hayashi Atushi (80411338)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 2 results
  • 14.  寺田 信一 (60861242)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 0 results
  • 15.  YAMADA Takashi (10182536)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 16.  ASAHI Michio (10397614)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 17.  Kanki Kazuyoshi (30770911)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 18.  Takai Masaaki (90770933)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 19.  藤田 太輔 (90411371)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 20.  鈴木 裕介 (90770925)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 21.  上田 尚子 (70920148)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 22.  劉 昌恵 (00849581)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 23.  NAKAMURA Kiyoko
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 24.  ITO Yuko
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to connect your ORCID iD to this researcher?
* This action can be performed only by the researcher themselves.

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi